Portfolio company
DNAmito
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops genomics-based decision support software to provide personalised radiation therapy treatment plans for cancer patients and clinicians.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
intoDNA
This company develops an AI-powered platform for detecting and quantifying DNA damage in cells to support pharmaceutical companies with drug development and diagnostics.
Mirada Medical
This company develops medical imaging software for clinicians to improve cancer diagnosis, treatment planning and radiotherapy workflows.
Synaptiq
This company develops artificial intelligence software for medical imaging to assist radiotherapy clinics with tumor and organ delineation for cancer treatment planning.
ptTheragnostic
This company develops clinical decision support software for oncologists to select between proton and photon therapy for cancer patients.
Oncompass
Oncompass develops oncology software that identifies genetic mutations to help clinicians select personalised cancer treatment options for patients.
Astron Health
This company develops a precision oncology platform that provides molecular data analysis and personalised treatment reports for cancer patients and their clinicians.
CollimateHealth
This company develops microbeam radiation technology for oncology clinics to treat cancer tumours through high-dose, narrow beams that activate immune responses.
DNA1
This company develops a platform for relating phenotype to genotype to accelerate discoveries in diagnostics, precision medicine, and genetics for healthcare organisations.
